PL EN


Preferences help
enabled [disable] Abstract
Number of results
2013 | 67 | 1 | 52–60
Article title

Współwystępowanie guzów narządów dokrewnych w przebiegu fakomatoz

Content
Title variants
EN
The coexistence of endocrine organ tumors in course of facomatoses
Languages of publication
PL
Abstracts
EN
The aim of this study is to draw attention to the coexistence of endocrine organ tumors and other symptoms commonly found in facomatoses. Facomatoses, otherwise known as neuro-cutaneous diseases are genetically conditioned neurodermatoses, which are observed in multiple tumors of many organs, including endocrine glands. Therefore, their knowledge is particularly important from the standpoint of a physician. The most common facomatoses have been discussed: von Recklinghausen’s disease (neurofibromatosis), tuberous sclerosis (Bourneville-Pringle’s syndrome), von Hipple-Lindau’s syndrome, Klippl-Trénaunay-Weber’s syndrome.
PL
Celem niniejszej pracy jest zwrócenie uwagi na współwystępowanie guzów narządów dokrewnych z innymi objawami spotykanymi w fakomatozach. Fakomatozy, zwane inaczej chorobami nerwowo-skórnymi lub neurodermatozami, są chorobami uwarunkowanymi genetycznie, w których obserwuje się liczne nowotwory wielu narządów, w tym także gruczołów wydzielania wewnętrznego. W związku z tym ich znajomość jest dla lekarza szczególnie ważna. Omówiono najczęściej występujące fakomatozy: chorobę von Recklinghausena (nerwiakowłókniakowatość), stwardnienie guzowate (zespół Bourneville’a-Pringle’a), zespół von Hippla-Lindaua oraz zespół Klippel-Trénaunay-Weber.
Discipline
Publisher

Year
Volume
67
Issue
1
Pages
52–60
Physical description
Contributors
  • Katedra i Zakład Anatomii Prawidłowej Wydziału Lekarskiego w Katowicach Śląskiego Uniwersytetu Medycznego w Katowicach ul. Medyków 18 40-762 Katowice tel. + 48 32 208 83 26, e-mail: lukas129@poczta.onet.pl
  • Katedra i Klinika Pediatrii Wydziału Lekarskiego z Oddziałem Lekarsko-Dentystycznym w Zabrzu
  • Katedra i Zakład Anatomii Prawidłowej Wydziału Lekarskiego w Katowicach
  • Koło Naukowe STN przy Katedrze i Zakładzie Anatomii Prawidłowej Wydziału Lekarskiego w Katowicach Śląskiego Uniwersytetu Medycznego w Katowicach
References
  • 1. Jóźwiak S. Fakomatozy. W: Neurologia dziecięca w praktyce. Red. S. Jóźwiak, R. Michałowicz. BiFolium, Lublin 2001: 251–271.
  • 2. Sucharzewska-Tomczak M., Grzegorzewska A. Zmiany nerwowo-skórne (fakomatozy) a choroby nerek. Nowiny Lek. 1999; 68: 961–965.
  • 3. Haslam R.H. Neurocutaneous syndromes. W: Nelson Text Book of Pediatrics. Red. R. Kliegman, R. Behrman, H. Jenson, B. Stanton. 18 th edition, Saunders Elsevier, Philadelphia 2007: 2483–2488.
  • 4. Henske E.P. Metastasis of benign tumor cells in tuberous sclerosis complex. Genes Chromosomes Cancer 2003; 38, 4: 376–381.
  • 5. Shepherd C.W., Gomez M.R., Lie J.T. i wsp. Causes of death in patients with tuberous sclerosis. Mayo Clin. Proc. 1992; 66: 792–796.
  • 6. Franz D.N. Non-neurologic manifestations of tuberous sclerosis complex. J. Child. Neurol. 2004; 19: 690–698.
  • 7. Jafri M., Maher E.R. The genetics of phaeochromocytoma: using clinical features to guide genetic testing. Eur. J. Endocrinol. 2012; 166: 151–158.
  • 8. Hari Kumar K.V., Shaikh A., Sandhu A.S., Prusty P. Neurofibromatosis 1 with pheochromocytoma. Indian J. Endocrinol. Metab. 2011; 15: 406–408.
  • 9. Sakorafas G.H., Giannopoulos G.A., Parasi A. i wsp. Large somatostatinproducing endocrine carcinoma of the ampulla of vater in association with GIST in a patient with von Recklinghausen's disease. Case report and review of the literature. JOP 2008; 9: 633–639.
  • 10. Walther M.M., Herring J., Enquist E., Keiser H.R., Linehan W.M. Von Recklinghausen's disease and pheochromocytomas. J. Urol. 1999; 162: 1582–1586.
  • 11. Cappelli C., Agosti B., Braga M. i wsp. Von Recklinghausen's neurofibromatosis associated with duodenal somatostatinoma. A case report and review of the literature. Minerva Endocrinol. 2004; 29: 19–24.
  • 12. Teramoto S., Ota T., Maniwa A. i wsp. Two von Recklinghausen's disease cases with pheochromocytomas and gastrointestinal stromal tumors (GIST) in combination. Int. J. Urol. 2007; 14: 73–74.
  • 13. Kamiya T., Yasui T., Suzuki O. i wsp. Von Recklinghausen's disease associated with pheochromocytoma- an autopsy case report and review of 24 cases in the Japanese literature. Gan. No. Rinsho. 1986; 32: 1872–1878.
  • 14. Babińska A., Gnacińska A., Swiatkowska-Stodulska R., Sworczak K. Myocardial infarction in a 30-year-old patient with pheochromocytoma and type 1 neurofibromatosis. Pol. Arch. Med. Wewn. 2008; 118: 517–523.
  • 15. Quarles Van Ufford-Mannesse P., Castro Cabezas M., Vroom T.M., Van Gils A., Lips C.J., Niermeijer P. A patient with neurofibromatosis type 1 and watery diarrhoea syndrome due to a VIP-producing adrenalphaeochromocytoma. J. Intern. Med. 1999; 246: 231–234.
  • 16. Onozawa M., Fukuhara T., Minoguchi M. i wsp. Hypokalemic rhabdomyolysis due to WDHA syndrome caused by VIP-producing compositepheochromocytoma: a case in neurofibromatosis type 1. Jpn. J. Clin. Oncol. 2005; 35: 559–563.
  • 17. Leung V.K., Lee S.W., Yuen N.W., Kung N.N., Loke T.K. Epigastric pain in a patient with neurofibromatosis type 1. Hong Kong Med. J. 2005; 11: 213–215.
  • 18. Pernet C., Kluger N., Du-Thanh A. i wsp. Somatostatin-producing endocrine tumour of the duodenum associated with type 1 neurofibromatosis. Acta Derm. Venereol. 2010; 90: 320–321.
  • 19. Behranwala K.A., Spalding D., Wotherspoon A., Fisher C.,Thompson J.N. Small bowel gastrointestinal stromal tumours and ampullary cancer in Type 1 neurofibromatosis. World J. Surg. Oncol. 2004; 2: 1.
  • 20. Lee W.S., Koh Y.S., Kim J.C. i wsp. Zollinger-Ellison syndrome associated with neurofibromatosis type 1: a case report. BMC Cancer 2005; 5: 85.
  • 21. Anagnostouli M., Piperingos G., Yapijakis C. i wsp. Thyroid gland neurofibroma in a NF1 patient. Acta Neurol. Scand. 2002; 106: 58–61.
  • 22. Koksal Y., Sahin M., Koksal H., Esen H., Sen M. Neurofibroma adjacent to the thyroid gland and a thyroid papillary carcinoma in a patient with neurofibromatosis type 1: report of a case. Surg. Today 2009; 39: 884–887.
  • 23. Segni M., Massa R., Bonifacio V. i wsp. Thyroid C-cell hyperplasia in an adolescent with neurofibromatosis type 1. Horm. Res. 2001; 56: 63–66.
  • 24. Demirjian A.N., Grossman J.M., Chan J.L., Parangi S. Parathyroid carcinoma and neurofibromatosis. Surgery 2008; 144: 827–829.
  • 25. Dworakowska D., Grossman A.B. Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review. Endocr. Relat. Cancer 2009; 16: 45–58.
  • 26. Lodish M.B., Stratakis C.A. Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes. Best Pract. Res. Clin. Endocrinol. Metab. 2010; 24: 439–449.
  • 27. Arva N.C., Pappas J.G., Bhatla T. i wsp. Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis--case report and review of the literature. Am. J. Surg. Pathol. 2012; 36: 149–153.
  • 28. Ogawa T., Mitsukawa T., Ishikawa T. i wsp. Familial pheochromocytoma associated with von Recklinghausen's disease. Intern. Med. 1994; 33: 110–114.
  • 29. Kim H., Kerr A., Morehouse H. The association between tuberous sclerosis and insulinoma. AJNR Am. J. Neuroradiol. 1995; 16: 1543–1544.
  • 30. Cavazza A., Roggeri A., Zini M., Rossi G., Zucchi L. Lymphangioleiomyomatosis associated with pulmonary metastasis from an occult papillarycarcinoma of the thyroid: report of a case occurring in a patient without tuberous sclerosis. Pathol. Res. Pract. 2002; 198: 825–828.
  • 31. Dicorato P., Calvanese A., Maiuolo A. i wsp. Medullary thyroid carcinoma and tuberous sclerosis. Endocr. Pathol. 2009; 20: 141–144.
  • 32. Flieder D.B., Travis W.D. Clear cell "sugar" tumor of the lung: association with lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in a patient with tuberous sclerosis. Am. J. Surg. Pathol. 1997; 10: 1242–1247.
  • 33. Boaz R.J., Ramakant P., Ebenazer A. i wsp. Role of cortical sparing adrenalectomy and novel variant of mutation in patient with von Hippel-Lindau disease. Indian J. Endocrinol. Metab. 2011; 15: 402–405.
  • 34. Opocher G., Conton P., Schiavi F., Macino B., Mantero F. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1. Fam. Cancer 2005; 4: 13–16.
  • 35. Zografos G.N., Vasiliadis G.K., Zagouri F. i wsp. Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends. World J. Surg. Oncol. 2010; 8: 14.
  • 36. Tamura K., Nishimori I., Ito T., Yamasaki I., Igarashi H., Shuin T. Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease. World J. Gastroenterol. 2010 28; 16: 4515–4518.
  • 37. Lewis R.B., Lattin G.E., Paal E. Pancreatic endocrine tumors: radiologicclinicopathologic correlation. Radiographics 2010; 30: 1445–1464.
  • 38. Iwamuro M., Kawamoto H., Shiraha H., Nose S., Yamamoto K. Pancreatic involvement in 11 cases of von hippel-lindau disease. Hepatogastroenterology 2012; 59: 589–591.
  • 39. Arkadopoulos N., Karapanos K., Stafyla V. i wsp. Combination of right nephrectomy and total pancreaticoduodenectomy for Von Hippel-Lindau disease. JOP. 2010; 11: 270–272.
  • 40. Weisbrod A.B., Liewehr D.J., Steinberg S.M. i wsp. Association of Type O Blood with Pancreatic Neuroendocrine Tumors in Von Hippel-LindauSyndrome. Ann. Surg. Oncol. 2012; 19: 2054–2059.
  • 41. Nakaji S., Hirata N., Kobayashi M. i wsp. Case of von Hippel-Lindau disease diagnosed by detection of multiple pancreatic endocrine tumors and renal tumor 13 years after bilateral adrenalectomy. Nihon Shokakibyo Gakkai Zasshi 2010; 107: 1978–1987.
  • 42. Kanno A., Satoh K., Hamada S. i wsp. Serous cystic neoplasms of the whole pancreas in a patient with von Hippel-Lindau disease. Intern. Med. 2011; 50: 1293–1298.
  • 43. Tudorancea A., François P., Trouillas J. i wsp. Von Hippel-Lindau disease and aggressive GH-PRL pituitary adenoma in a young boy. Ann. Endocrinol. 2012; 73: 37–42.
  • 44. Kramer K., Hasel C., Aschoff A.J. i wsp. Multiple gastrointestinal stromal tumors and bilateral pheochromocytoma in neurofibromatosis. World. J. Gastroenterol. 2007; 13: 3384–3387.
  • 45. Whelan M., Watson M.S., Porter F.D. i wsp. Klippel-Trenaunay-Weber syndrome associated with a 5:11 balanced translocation. Am. J. Med. Genet.1995; 59: 492–494.
  • 46. Furukawa T., Igata A., Toyokura Y. i wsp. Sturge-Weber and Klippel-Trenaunay syndrome with nevus of Ota and Ito. Arch. Dermatol. 1970; 102: 640–645.
  • 47. Karbowniczek M., Astrinidis A., Balsara B.R. i wsp. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am. J. Respir. Crit. Care Med. 2003; 167: 976–982.
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-5c4a1e2e-0890-4993-bdb6-9b4cb73dcfc4
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.